OPKO Health
OPKO Health

OPKO Health

Health Care Providers & Services
WebsiteInvestor RelationsSEC
OPKO Health Inc is a diversified biotechnology company that operates pharmaceutical and diagnostic development programs. Its segments include pharmaceutical and diagnostics. The Pharmaceutical segment consists of its pharmaceutical operations in Chile, Mexico, Ireland, Israel, Spain, Ecuador, France, the United States, and its pharmaceutical research and development operations. The Diagnostics segment consists of clinical and genomics laboratory operations through BioReference and point-of-care operations. It generates the majority of its revenue from the Diagnostics segment.

$1.2B

Market Cap • 9/25/2026

1991

(35 years)

Founded

1995

(31 years ago)

IPO

NASDAQ

Listing Exchange

Flag of United States

United States

Country

Valuation

P/B

0,9

P/S

1,9

P/EBITDA

—

P/OCF

—

P/FCF

—

P/E

—

BVPS

1,6

EPS

—

Market Cap

Market Cap

1,2B

EV

1,2B

EV/Revenue

1,8

EV/EBITDA

-61,5

EV/EBIT

-10,4

Payout

Dividend Per Share

0

Dividend Yield

0%

Buyback Yield

4,2%

Total Yield

4,2%

Payout

0%

Retained Earnings

-2,3B

Profitability

Gross Margin

35,3%

EBITDA Margin

—

EBIT Margin

—

Net Margin

—

D&A/EBITDA

0%

R&D/Revenue

19%

Capex/Revenue

2,3%

Capex/D&A

16,1%

Capex/OCF

-7,6%

SBC/OCF

—

% PPE

6%

% Goodwill

24,3%

ROE

—

ROIC

—

Growth

CAGR Revenue 5Y

-11,2%

CAGR Op. Income 5Y

1,5%

CAGR Net Income 5Y

9,6%

CAGR EPS 5Y

6,8%

CAGR OCF 5Y

37%

Leverage

N.D./EBITDA

1,4

Debt/Equity

0%

Current Ratio

3,7

Quick Ratio

3

Interest Coverage

—

Premium

Unlock 100% of the data and have immediate access on more than 6.000 companies with updated information!
  • Unrestricted access
  • Unlimited data history
  • Analysis videos
  • Quarterly highlights
  • Customizable financials table
  • Ranking
  • Discussions

...and much more!

Get Premium